Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000401178

Medchemexpress LLC Avitinib maleate | 1557268-88-8 | 99.9% | 603.60 | 50 MG
SDP

Catalog No. 5000401178
Encompass_Preferred

Avitinib maleate (Abivertinib maleate) is a third-generation, irreversible and orally active selective EGFR inhibitor. It also functions as a BTK inhibitor that induces apoptosis and inhibits phosphorylation of BTK in mantle cell lymphoma. It demonstrates anticancer effects.

  • Third-generation, irreversible, and orally active selective EGFR inhibitor.
  • Potent against EGFR L858R, EGFR T790M, and wild-type EGFR.
  • BTK inhibitor.
  • Induces apoptosis.
  • Inhibits phosphorylation of BTK in mantle cell lymphoma.
  • Shows anticancer effects.

Catalog No. 50-004-01178 Supplier Medchemexpress LLC Supplier No. HY19816A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Avitinib maleate (Abivertinib maleate) is a third-generation, irreversible and orally active selective EGFR inhibitor. It also functions as a BTK inhibitor that induces apoptosis and inhibits phosphorylation of BTK in mantle cell lymphoma. It demonstrates anticancer effects.

  • Third-generation, irreversible, and orally active selective EGFR inhibitor.
  • Potent against EGFR L858R, EGFR T790M, and wild-type EGFR.
  • BTK inhibitor.
  • Induces apoptosis.
  • Inhibits phosphorylation of BTK in mantle cell lymphoma.
  • Shows anticancer effects.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.